GlaxoSmithKline jumps into myeloma with ‘homemade’ anti-BCMA drug Blenrep chelfand Thu, 08/06/2020 – 02:48

AstraZeneca takes COVID-19 vaccine to China with BioKangtai deal for 200M-dose capacity by 2021 aliu Thu, 08/06/2020 – […]

Vaccine was generally well-tolerated with only a few mild side-effects reported

Draft guidance says some commonly used drug treatments should be avoided

Drug is first biologic in Europe to be approved with a dose reduction label for axSpA patients

Drug reduced annual rate of asthma exacerbations by 49%

Updated Date: Wed, 29 Jul 2020 00:00:00 EDT

Updated Date: Wed, 29 Jul 2020 00:00:00 EDT

Updated Date: Wed, 29 Jul 2020 00:00:00 EDT

Updated Date: Wed, 29 Jul 2020 00:00:00 EDT